<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36157560</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1937-8688</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>Suppl 1</Issue><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>The Pan African medical journal</Title><ISOAbbreviation>Pan Afr Med J</ISOAbbreviation></Journal><ArticleTitle>An assessment of the contribution of National Stop Transmission of Polio Program to Nigeria's Immunization Program.</ArticleTitle><Pagination><StartPage>1</StartPage><MedlinePgn>1</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.11604/pamj.supp.2021.40.1.15816</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">In July 2012, the National Stop Transmission of Polio (NSTOP) program was established to support the Government of Nigeria in interrupting transmission of poliovirus and strengthen routine immunization (RI). NSTOP has approximately 300 staff members with the majority based at the Local Government Area (LGA) level in northern Nigeria.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">An internal assessment of NSTOP was conducted from November 2015 to February 2016 to document the program´s contribution to Nigeria´s immunization program and plan future NSTOP engagement. A mixed methods design was used, with data gathered from health facility, LGA, state, and national levels, through structured surveys, interviews, focus group discussions, and review of program records. Survey and expenditure data were summarized by frequency and trends over time, while interview and focus group data were analyzed qualitatively for key themes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The majority of the 111 non-NSTOP LGA respondents reported that NSTOP officers supported polio campaigns (100%) and supervised RI sessions (99.1%). Out of 181 respondents at health facility level, the majority reported that NSTOP trainings improved their knowledge (83.3%) and skills (76.2%) on RI, and NSTOP officers regularly supervised their RI sessions (96.7%). Most respondents reported that there would be a negative impact on immunization activities if NSTOP officers were withdrawn.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Future implementation of NSTOP should be realigned to (a) give highest priority to mentoring LGA staff to build institutional capacity, (b) ensure increased capacity translates to improved provision of RI services, and (c) improve routine review of program monitoring data to assess progress in both polio and RI programs.</AbstractText><CopyrightInformation>©Oladayo Biya et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Biya</LastName><ForeName>Oladayo</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Polio Eradication Branch, Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Archer</LastName><ForeName>Wiedad Roodly</ForeName><Initials>WR</Initials><AffiliationInfo><Affiliation>Polio Eradication Branch, Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rayner</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Control of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Welwean</LastName><ForeName>Ralph</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Polio Eradication Branch, Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jegede</LastName><ForeName>Ayodele</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Sociology, University of Ibadan, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacenko</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pallas</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abimbola</LastName><ForeName>Taiwo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>Kirsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiesen</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Polio Eradication Branch, Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Uganda</Country><MedlineTA>Pan Afr Med J</MedlineTA><NlmUniqueID>101517926</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D060740" MajorTopicYN="N">Disease Eradication</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007114" MajorTopicYN="N">Immunization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017589" MajorTopicYN="N">Immunization Programs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009549" MajorTopicYN="N" Type="Geographic">Nigeria</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Government of Nigeria</Keyword><Keyword MajorTopicYN="N">National Stop Transmission of Polio (NSTOP) program</Keyword><Keyword MajorTopicYN="N">poliovirus</Keyword><Keyword MajorTopicYN="N">program evaluation</Keyword><Keyword MajorTopicYN="N">routine immunization</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>26</Day><Hour>17</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36157560</ArticleId><ArticleId IdType="pmc">PMC9474955</ArticleId><ArticleId IdType="doi">10.11604/pamj.supp.2021.40.1.15816</ArticleId><ArticleId IdType="pii">PAMJ-SUPP-40-1-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Primary Health Care Development Agency (NPHCDA) Nigeria National Polio Eradication Emergency Plan. 2012.</Citation></Reference><Reference><Citation>Waziri NE, Ohuabunwo CJ, Nguku PM, Ogbuanu IU, Gidado S, Biya O, Wiesen ES. Polio eradication in Nigeria and the role of the National Stop Transmission of Polio Program, 2012-2013. J Infect Dis. 2014;210(Suppl 1):S111–S117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10617670</ArticleId><ArticleId IdType="pubmed">25316824</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr Y, Mailhot M, Williams AAJ, Swezy V, Quick L, Tangermann RH, et al. Lessons learned and legacy of the stop transmission of polio program. J Infect Dis. 2017;216(suppl_1):S316–S323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5853610</ArticleId><ArticleId IdType="pubmed">28838200</ArticleId></ArticleIdList></Reference><Reference><Citation>Gidado SO, Ohuabunwo C, Nguku PM, Ogbuanu IU, Waziri NR, Biya O, et al. Outreach to underserved communities in northern Nigeria, 2012-2013. J Infect Dis. 2014;210(Suppl 1):S118–S124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10546473</ArticleId><ArticleId IdType="pubmed">25316825</ArticleId></ArticleIdList></Reference><Reference><Citation>Osadebe LU, MacNeil A, Elmousaad H, Davis L, Idris JM, Haladu SA, et al. Assessing Inactivated Polio Vaccine Introduction and Utilization in Kano State, Nigeria, April-November 2015. J Infect Dis. 2017;216(suppl_1):S137–S145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5844228</ArticleId><ArticleId IdType="pubmed">28838186</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Department of Health and Human Services Centers for Disease Control and Prevention . Introduction to program evaluation for public health programs: A self-study guide. 2011. Office of the Director, Office of Strategy and Innovation.</Citation></Reference><Reference><Citation>Creswell JW, Clark VLP. 200 Thousand Oaks, CA. SAGE. Designing and conducting mixed methods research - 2nd edition.</Citation></Reference><Reference><Citation>Oku A, Oyo-Ita A, Glenton C, Fretheim A, Eteng G, Ames H, et al. Factors affecting the implementation of childhood vaccination communication strategies in Nigeria: a qualitative study. BMC Public Health. 2017;17(1):200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5311723</ArticleId><ArticleId IdType="pubmed">28202001</ArticleId></ArticleIdList></Reference><Reference><Citation>Isibor I, Gasasira A, Mkanda P, Weldegriebriel G, Bassey BE, Toritseju MS, et al. Rapid assessments of acute flaccid paralysis surveillance in seven key polio high risk states in Northern Nigeria. Peak J Med Med Sci. 2014;2(3):33–40.</Citation></Reference><Reference><Citation>Grimshaw J, Campbell M, Eccles M, Steen N. Experimental and quasi-experimental designs for evaluating guideline implementation strategies. Family practice. 2000;17(suppl_1):S11–S16.</Citation><ArticleIdList><ArticleId IdType="pubmed">10735262</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagarde M. How to do (or not to do). Assessing the impact of a policy change with routine longitudinal data. Health Policy and Planning. 2012;27(1):76–83.</Citation><ArticleIdList><ArticleId IdType="pubmed">21278077</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>